Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Translocation t(14;18) and gain of chromosome 18/BCL2: effects on BCL2 expression and apoptosis in B-cell non-Hodgkin's lymphomas.

Galteland E, Sivertsen EA, Svendsrud DH, Smedshammer L, Kresse SH, Meza-Zepeda LA, Myklebost O, Suo Z, Mu D, Deangelis PM, Stokke T.

Leukemia. 2005 Dec;19(12):2313-23.

PMID:
16193090
2.

B-cell non-Hodgkin's lymphoma cell line (Karpas 1106) with complex translocation involving 18q21.3 but lacking BCL2 rearrangement and expression.

Nacheva E, Dyer MJ, Metivier C, Jadayel D, Stranks G, Morilla R, Heward JM, Holloway T, O'Connor S, Bevan PC, et al.

Blood. 1994 Nov 15;84(10):3422-8.

3.

Rearrangement of the BCL6 gene in B-cell lymphoid neoplasms: comparison with lymphomas associated with BCL2 rearrangement.

Muramatsu M, Akasaka T, Kadowaki N, Ohno H, Yamabe H, Edamura S, Dor S, Mori T, Okuma M, Fukuhara S.

Br J Haematol. 1996 Jun;93(4):911-20.

PMID:
8703825
4.

Gain of chromosome region 18q21 including the MALT1 gene is associated with the activated B-cell-like gene expression subtype and increased BCL2 gene dosage and protein expression in diffuse large B-cell lymphoma.

Dierlamm J, Murga Penas EM, Bentink S, Wessendorf S, Berger H, Hummel M, Klapper W, Lenze D, Rosenwald A, Haralambieva E, Ott G, Cogliatti SB, Möller P, Schwaenen C, Stein H, Löffler M, Spang R, Trümper L, Siebert R; Deutsche Krebshilfe Network Project "Molecular Mechanisms in Malignant Lymphomas".

Haematologica. 2008 May;93(5):688-96. doi: 10.3324/haematol.12057. Epub 2008 Mar 26.

5.

B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome.

Li S, Lin P, Fayad LE, Lennon PA, Miranda RN, Yin CC, Lin E, Medeiros LJ.

Mod Pathol. 2012 Jan;25(1):145-56. doi: 10.1038/modpathol.2011.147. Epub 2011 Oct 14.

6.

Concurrent activation of MYC and BCL2 in B cell non-Hodgkin lymphoma cell lines by translocation of both oncogenes to the same immunoglobulin heavy chain locus.

Dyer MJ, Lillington DM, Bastard C, Tilly H, Lens D, Heward JM, Stranks G, Morilla R, Monrad S, Guglielmi P, Kluin-Nelemans JC, Hagemeijer A, Young BD, Catovsky D.

Leukemia. 1996 Jul;10(7):1198-208.

PMID:
8684002
7.

MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma.

Sanchez-Izquierdo D, Buchonnet G, Siebert R, Gascoyne RD, Climent J, Karran L, Marin M, Blesa D, Horsman D, Rosenwald A, Staudt LM, Albertson DG, Du MQ, Ye H, Marynen P, Garcia-Conde J, Pinkel D, Dyer MJ, Martinez-Climent JA.

Blood. 2003 Jun 1;101(11):4539-46. Epub 2003 Jan 30.

8.

Bcl-2 rearrangements with breakpoints in both vcr and mbr in non-Hodgkin's lymphomas and chronic lymphocytic leukaemia.

Merup M, Spasokoukotskaja T, Einhorn S, Smith CI, Gahrton G, Juliusson G.

Br J Haematol. 1996 Mar;92(3):647-52.

PMID:
8616030
9.

BCL2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma.

Monni O, Joensuu H, Franssila K, Klefstrom J, Alitalo K, Knuutila S.

Blood. 1997 Aug 1;90(3):1168-74.

10.

Immunohistochemical expression of CD10 and t(14;18) chromosomal translocation may be indicators of follicle centre cell origin in nodal diffuse large B-cell lymphoma.

McCluggage WG, Catherwood M, Alexander HD, McBride HA, Smith ME, Morris TC.

Histopathology. 2002 Nov;41(5):414-20.

PMID:
12405909
11.

Neoplastic cells do not carry bcl2-JH rearrangements detected in a subset of primary cutaneous follicle center B-cell lymphomas.

Vergier B, Belaud-Rotureau MA, Benassy MN, Beylot-Barry M, Dubus P, Delaunay M, Garroste JC, Taine L, Merlio JP.

Am J Surg Pathol. 2004 Jun;28(6):748-55.

PMID:
15166666
12.

BCL2 translocations in leukemias of mature B cells.

Dyer MJ, Zani VJ, Lu WZ, O'Byrne A, Mould S, Chapman R, Heward JM, Kayano H, Jadayel D, Matutes E, et al.

Blood. 1994 Jun 15;83(12):3682-8.

13.
14.

Molecular features of a new human lymphoma cell line carrying both BCL2 and BCL6 gene rearrangements.

Yonetani N, Akasaka T, Akasaka H, Ohno H, Okuma M, Miura I, Takahashi N, Miyanishi S, Okumura A, Muramatsu M, Fukuhara S.

Oncogene. 1998 Aug 27;17(8):971-9.

15.

B-cell non-Hodgkin's lymphoma: evidence for the t (14;18) translocation in all hematopoietic cell lineages.

Yarkoni S, Lishner M, Tangi I, Nagler A, Lorberboum-Galski H.

J Natl Cancer Inst. 1996 Jul 17;88(14):973-9.

16.
17.

Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component.

Katzenberger T, Ott G, Klein T, Kalla J, Müller-Hermelink HK, Ott MM.

Am J Pathol. 2004 Aug;165(2):481-90.

18.

Cytogenetic, molecular biological and clinical study of B-cell lymphomas with 14;18 translocation in Japanese patients.

Takechi M, Tanaka K, Hashimoto T, Asaoku H, Dohy H, Kikuchi M, Kamada N.

Leukemia. 1991 Dec;5(12):1069-75.

PMID:
1774956
19.

Absence of the t(14;18) chromosomal translocation in primary cutaneous B-cell lymphoma.

Child FJ, Russell-Jones R, Woolford AJ, Calonje E, Photiou A, Orchard G, Whittaker SJ.

Br J Dermatol. 2001 Apr;144(4):735-44.

PMID:
11298531
20.

Gene amplification of Japanese non-Hodgkin lymphoma with involvement of the BCL2 gene.

Miyamura K, Kobayashi T, Sasaki T, Ibuka T, Imai K, Sakai Y, Kawaguchi K, Miyashita T, Iwaya M, Mizutani S.

Int J Hematol. 1991 Apr;54(2):137-40.

PMID:
1747446
Items per page

Supplemental Content

Write to the Help Desk